Avalo Therapeutics (AVTX) Other Operating Expenses (2017 - 2026)
Avalo Therapeutics (AVTX) posted Other Operating Expenses of $6.57 million for Q2 2026.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Other Operating Expenses (2017 - 2026) Analysis & Trends
For FY2024, Avalo Therapeutics' Other Operating Expenses came in at $27.28 million, up 425.4% from FY2023.
- Annual Other Operating Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 93.7% (FY2019 to FY2024).
- In prior years, Avalo Therapeutics' Other Operating Expenses was $5.19 million in FY2023 (+49.5%), $3.47 million in FY2022 (+14.2%), $3.04 million in FY2021 (-89.8%) and $29.93 million in FY2020.
- The Q2 2026 figure stands as the highest quarterly Other Operating Expenses since Q1 2024.
- The strongest year-over-year quarter for Other Operating Expenses in the past five years was Q4 2023, with growth of 494.5%; the weakest was Q4 2024, with a decline of 97.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Avalo Therapeutics | 668.42 Mn | 668.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.57 Mn |
| Dec 31, 2024 | 87,000.00 |
| Sep 30, 2024 | -714,000.00 |
| Jun 30, 2024 | 446,000.00 |
| Mar 31, 2024 | 27.46 Mn |
| Dec 31, 2023 | 3.69 Mn |
| Sep 30, 2023 | 247,000.00 |
| Jun 30, 2023 | 708,000.00 |
| Mar 31, 2023 | 551,000.00 |
| Dec 31, 2022 | 620,000.00 |
| Sep 30, 2022 | 528,000.00 |
| Jun 30, 2022 | 1.57 Mn |
| Mar 31, 2022 | 758,000.00 |
| Dec 31, 2021 | 691,000.00 |
| Sep 30, 2021 | 1.34 Mn |
| Jun 30, 2021 | 511,000.00 |
| Mar 31, 2021 | 936,000.00 |
| Dec 31, 2020 | 1.13 Mn |
| Sep 30, 2020 | 943,000.00 |
| Jun 30, 2020 | 1.14 Mn |
API Access
Avalo Therapeutics Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();